| Abstract | A 60-year-old man with bilateral lung metastases from breast cancer was treated with the gonadotropin-releasing hormone analogue, buserelin, given as an intranasal spray. Androgen deprivation and complete remission of lung metastases were achieved with minimal side effects. Androgen deprivation by means of nasally administered buserelin offers an easy and efficient alternate approach in the treatment of metastatic male breast cancer. |
| Authors | D A Vorobiof, G Falkson |
| Journal | Cancer
(Cancer)
Vol. 59
Issue 4
Pg. 688-9
(Feb 15 1987)
ISSN: 0008-543X UNITED STATES |
| PMID | 3100015
(Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
|
| Chemical References |
|
| Topics |
- Administration, Intranasal
- Breast Neoplasms
(pathology)
- Buserelin
(administration & dosage)
- Humans
- Lung Neoplasms
(drug therapy, secondary)
- Male
- Middle Aged
|
